Sean Wharton The first coprimary endpoint of mean change in body weight at 72 weeks was 18.7% in the semaglutide 7.2 mg group, 15.6% in the semaglutide 2.4 mg group and 3.9% in the placebo group (estimated treatment difference between semaglutide 7.2 mg and semaglutide 2.4 mg, 3.1 percentage points
The mild loose bowel movements I experienced were a small price to pay compared to Ozempic's effects, and definitely more manageable
As part of a medically supervised program, Semaglutide can help you lose weight safely and effectively while addressing other metabolic health concerns
These preferences influence how care is guided over time
The most successful users, including many of the Brello positive reviewers, report combining the medication with meaningful dietary and lifestyle changes
Do not change, adjust, or discontinue any medications without your physician's guidance and approval